Cha Albert 4
4 · KalVista Pharmaceuticals, Inc. · Filed Sep 13, 2023
Insider Transaction Report
Form 4
Cha Albert
Director
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2023-09-11−6,000→ 0 totalExercise: $6.71Exp: 2027-09-27→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2023-09-11$7.88/sh+12,000$94,560→ 18,000 total - Exercise/Conversion
Common Stock
2023-09-11$6.71/sh+6,000$40,260→ 6,000 total - Sale
Common Stock
2023-09-11$10.50/sh−18,000$189,050→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-09-11−12,000→ 0 totalExercise: $7.88Exp: 2027-03-22→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.38 to $10.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]The option is fully vested.